The largest database of trusted experimental protocols

5 protocols using 1 2 13c glucose

1

Mycoplasma-Free Cell Culture for Metabolic Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
LPS224, LPS246, T1000, SW872, HT1080, KP250 and 293T cells were tested to confirm they are mycoplasma negative, and cultured in DMEM (Life Technologies, 11965–084) containing 10% FBS (Gemini, 900–108). C2C12 myoblasts (ATCC, CRL-1772) were propagated in DMEM containing 20% FBS. To evaluate differentiation, myoblasts were grown to 80 to 90% confluence and switched to 2% horse serum (Life Technologies, 16050–122) in DMEM. For metabolic labelling assays, cells were maintained in glucose-free DMEM (Life Technologies, 11966–025) supplemented with 10% dialyzed FBS (Gemini, 100–108) and 10 mM [1, 2-13C]glucose (Sigma-Aldrich, 453188), or supplemented with 10% dialyzed FBS and 2 mM [3-13C]sodium pyruvate (Sigma-Aldrich, 490733).
+ Open protocol
+ Expand
2

Breast Cancer Cell Line Metabolism

Check if the same lab product or an alternative is used in the 5 most similar protocols
MCF 10A (ATCC CRL-10317), MCF7 (ATCC HTB-22) and MDA-MB-231 (ATCC HTB-26) cells were from the American Tissue Culture Collection (ATCC). MCF 10A cells are a non-tumorigenic breast cell line, MCF7 cells are a tumorigenic, luminal breast cancer cell line, and MDA-MB-231 cells are a metastatic, basal breast cancer cell line [30 (link)]. Dulbecco’s modified Eagle medium (DMEM) without glucose, glutamine, sodium pyruvate, and phenol red (Life Technologies) was used as the growth media. The growth media was supplemented to contain 5 mM glucose (Thermo Fisher), 3 mM glutamine (Life Technologies), 10% dialyzed fetal bovine serum (dFBS, Life Technologies), 100 U/mL penicillin, and 100 μg/mL streptomycin (100X Penicillin-Streptomycin solution, Life Technologies). High-lactate cultures were supplemented with 10 mM sodium L-lactate (Sigma) for the MCF 10A cultures and 20 mM for the MCF7 and MDA-MB-231 cultures. The isotopic tracers were [1,2-13C] glucose, [U-13C] L-glutamine, and [U-13C] sodium lactate, all purchased from Sigma-Aldrich.
+ Open protocol
+ Expand
3

Metabolic Labeling with 13C-Glucose Isotopes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The labeling substrates, [1-13C]glucose (99 atom%), [1,2-13C]glucose (99 atom%), and [13C6]glucose (99 atom%), were purchased from Sigma-Aldrich. Derivatization agents TBDMS [N-methyl-N-(t-butyldimethylsilyl) trifluoroacetamide plus 1% t-butyl-dimethylchlorosilane] and MSTFA [N-methyl-N-(trimethylsilyl) trifluroacetamide] were also purchased from Sigma-Aldrich. Medium components and other reagents were purchased from Himedia and Sigma-Aldrich.
+ Open protocol
+ Expand
4

Microbial γ-PGA Production via Labeled Glucose

Check if the same lab product or an alternative is used in the 5 most similar protocols
Strains and plasmids used in this study were provided in Table 1. B. licheniformis WX-02 was acted as the original strain for constructing recombinants, and E. coli DH5α was served as the host strain for plasmid construction. B. licheniformis and E. coli were grown in LB medium with responsible antibiotic (20 μg/mL kanamycin, 100 μg/mL ampicillin, or 20 μg/mL tetracycline), when required.
The γ-PGA fermentation medium contains 20 g/L glucose, 5 g/L NH4NO3, 11.35 g/L Na2HPO4, 8.15 g/L KH2PO4, 0.20 g/L MgSO4⋅7H2O, 0.01 g/L MnSO4⋅H2O, 0.0008 g/L CaCl2, and 0.0045 g/L Na2-EDTA. B. licheniformis were grown in twenty-four well plates with 2 mL working volume, and cultivated at 220 rpm and 37°C for 14 h. For 13C-MFA, glucose was replaced by [1, 2-13C] glucose (Sigma-Aldrich, CAS#138079-87-5) in γ-PGA production medium.
+ Open protocol
+ Expand
5

Metabolic Tracing of TNBC Biopsies

Check if the same lab product or an alternative is used in the 5 most similar protocols
On day of biopsy, patients undergoing infusion received a 6g bolus of [1,2-13C]glucose in normal saline through a peripheral IV over 10 min followed by 6 g/h continuous infusion until they underwent needle biopsy of their primary breast cancer. Prior to infusion, the [1,2-13C]glucose (Sigma-Aldrich) underwent sterility and endotoxin testing. The target interval from start of bolus to biopsy was 60 min.
For percutaneous core needle biopsies of primary TNBCs, breast area was prepped adjacent to the mass. Using ultrasound for localization, the skin and peritumoral area was infiltrated with local anesthetic and a small dermal incision was made, through which six 14-gauge core biopsies were obtained with ultrasound guidance. Biopsies were immediately dispensed into crytotubes pre-cooled on dry ice. Tubes were sealed and stored at −80°C.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!